TNFRSF12A

From WikiMD's WELLNESSPEDIA

(Redirected from TWEAK receptor)


TNFRSF12A
Symbol TNFRSF12A
HGNC ID 11906
Alternative symbols
Entrez Gene 51330
OMIM 604967
RefSeq NM_016639
UniProt Q9NP84
Chromosome 16p13.3
Locus supplementary data


TNFRSF12A (Tumor Necrosis Factor Receptor Superfamily Member 12A) is a gene that encodes a member of the tumor necrosis factor receptor superfamily. This receptor is also known as FN14 and is the smallest member of this family. It is involved in various cellular processes, including cell proliferation, apoptosis, and inflammation.

Function[edit]

The TNFRSF12A gene product is a receptor for the cytokine TWEAK (TNF-like weak inducer of apoptosis). The interaction between FN14 and TWEAK can activate several signaling pathways, including the NF-kB pathway, which plays a crucial role in immune response and cell survival.

Clinical Significance[edit]

Alterations in the expression of TNFRSF12A have been associated with various diseases, including cancer, atherosclerosis, and autoimmune disorders. Overexpression of FN14 has been observed in several types of tumors, suggesting a role in tumor progression and metastasis.

Research[edit]

Research on TNFRSF12A is ongoing to better understand its role in disease and its potential as a therapeutic target. Studies are exploring the use of FN14 inhibitors in the treatment of cancer and other diseases characterized by chronic inflammation.

See Also[edit]

References[edit]


External Links[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.